References - Homocysteine in Protein Structure/Function and Human Disease - page 149

358. Perna AF, Capasso R, Lombardi C, Acanfora F, Satta E, Ingrosso D. Hyperhomocysteinemia
and macromolecule modifications in uremic patients. Clin Chem Lab Med. 2005;43
(10):1032-8.
359. Wang W, Escobedo JO, Lawrence CM, Strongin RM. Direct detection of homocysteine. J
Am Chem Soc. 2004;126(11):3400-1.
360. Wang W, Rusin O, Xu X, Kim KK, Escobedo JO, Fakayode SO, et al. Detection of
homocysteine and cysteine. J Am Chem Soc. 2005;127(45):15949-58.
361. Mosesson MW, Sherry S. The preparation and properties of human fibrinogen of relatively
high solubility. Biochemistry. 1966;5(9):2829-35.
362. Gu W, Lu J, Yang G, Dou J, Mu Y, Meng J, et al. Plasma homocysteine thiolactone
associated with risk of macrovasculopathy in Chinese patients with type 2 diabetes mellitus.
Adv Ther. 2008;25(9):914-24.
363. Kokame K, Kato H, Miyata T. Homocysteine-respondent genes in vascular endothelial cells
identified by differential display analysis. GRP78/BiP and novel genes. J Biol Chem.
1996;271(47):29659-65.
364. Outinen PA, Sood SK, Liaw PC, Sarge KD, Maeda N, Hirsh J, et al. Characterization of the
stress-inducing effects of homocysteine. Biochem J. 1998;332(Pt 1):213-21.
365. Althausen S, Paschen W. Homocysteine-induced changes in mRNA levels of genes coding
for cytoplasmic- and endoplasmic reticulum-resident stress proteins in neuronal cell cultures.
Brain Res Mol Brain Res. 2000;84(1-2):32-40.
366. Kokame K, Agarwala KL, Kato H, Miyata T. Herp, a new ubiquitin-like membrane protein
induced by endoplasmic reticulum stress. J Biol Chem. 2000;275(42):32846-53.
367. Kaufman RJ. Stress signaling from the lumen of the endoplasmic reticulum: coordination of
gene transcriptional and translational controls. Genes Dev. 1999;13(10):1211-33.
368. Mori K. Tripartite management of unfolded proteins in the endoplasmic reticulum. Cell.
2000;101(5):451-4.
369. Werstuck GH, Lentz SR, Dayal S, Hossain GS, Sood SK, Shi YY, et al. Homocysteine-
induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride
biosynthetic pathways. J Clin Invest. 2001;107(10):1263-73.
370. Anfinsen CB. Principles that govern the folding of protein chains. Science. 1973;181
(96):223-30.
371. Stefani M. Protein misfolding and aggregation: new examples in medicine and biology of the
dark side of the protein world. Biochim Biophys Acta. 2004;1739(1):5-25.
372. Mallamaci F, Zoccali C, Tripepi G, Fermo I, Benedetto FA, Cataliotti A, et al. Hyperhomo-
cysteinemia predicts cardiovascular outcomes in hemodialysis patients. Kidney Int. 2002;61
(2):609-14.
373. Perła-Kaj ´ n J, Stanger O, Zi ´ łkowska A, Melandowicz LK, Twardowski T, Jakubowski H.
Immunohistochemical detection of N-homocysteinylated proteins in cardiac surgery patients.
Clin Chem Lab Med. 2007;45(5):A36.
374. Libby P. Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr. 2006;83
(2):456S-60.
375. Forrester JS, Libby P. The inflammation hypothesis and its potential relevance to statin
therapy. Am J Cardiol. 2007;99(5):732-8.
376. Binder CJ, Shaw PX, Chang MK, Boullier A, Hartvigsen K, Horkko S, et al. The role of
natural antibodies in atherogenesis. J Lipid Res. 2005;46(7):1353-63.
377. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105
(9):1135-43.
378. Lopes-Virella MF, Thorpe SR, Derrick MB, Chassereau C, Virella G. The immunogenicity of
modified lipoproteins. Ann N Y Acad Sci. 2005;1043:367-78.
379. Undas A, Kolarz M, Kopec G, Glowacki R, Placzkiewicz-Jankowska E, Tracz W.
Autoantibodies against N-homocysteinylated proteins in patients on long-term

haemodialysis. Nephrol Dial Transplant. 2007;22(6):1685-9.